Veracyte Inc (VCYT) — Cash Flow-to-Debt Ratio
Veracyte Inc (VCYT) has a Cash Flow-to-Debt Ratio of 0.41x as of September 2025, meaning its operating cash flow of $44.76 Million could theoretically repay 0% of its total liabilities ($110.12 Million) in one year. Check Veracyte Inc (VCYT) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Veracyte Inc Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Veracyte Inc across 14 annual periods. Also explore Veracyte Inc (VCYT) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Veracyte Inc (2011–2024)
Year-by-year debt coverage analysis for Veracyte Inc. For market capitalisation and broader financial context, see Veracyte Inc (VCYT) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.61x | $75.10 Million | $124.07 Million | ▼ -3.1% |
| 2023 | 0.62x | $44.22 Million | $70.80 Million | ▲ +573.2% |
| 2022 | 0.09x | $7.54 Million | $81.22 Million | ▲ +126.8% |
| 2021 | -0.35x | $-31.62 Million | $91.31 Million | ▼ -28.1% |
| 2020 | -0.27x | $-9.71 Million | $35.93 Million | ▼ -199.0% |
| 2019 | -0.09x | $-3.23 Million | $35.76 Million | ▲ +72.7% |
| 2018 | -0.33x | $-13.52 Million | $40.88 Million | ▲ +42.7% |
| 2017 | -0.58x | $-23.91 Million | $41.44 Million | ▲ +14.5% |
| 2016 | -0.68x | $-27.98 Million | $41.45 Million | ▲ +39.8% |
| 2015 | -1.12x | $-26.96 Million | $24.03 Million | ▲ +4.7% |
| 2014 | -1.18x | $-27.63 Million | $23.46 Million | ▼ -42.5% |
| 2013 | -0.83x | $-19.16 Million | $23.19 Million | ▼ -63.3% |
| 2012 | -0.51x | $-7.17 Million | $14.17 Million | ▲ +92.8% |
| 2011 | -7.04x | $-13.52 Million | $1.92 Million | — |